Tag Archives: GI

April, 2017

7 April
Finch Therapeutics and Takeda Enter New Microbiome GI Collaboration

Osaka, Japan and Somerville, MA, April 5 2017 – Finch Therapeutics, a privately held microbiome engineering company, and Takeda Pharmaceutical Company Limited (“Takeda”) (TSE: 4502), today announced a global collaboration agreement to jointly develop FIN-524. FIN-524 is a live biotherapeutic product in pre-clinical research. It is composed of cultured bacterial …
Share

22 January
Celgene Will Present Data from 10 Abraxane-Related Studies at ASCO GI Symposium

SUMMIT, NJ– (Jan. 22, 2016) – Celgene Corporation (NASDAQ: CELG) today announced that 10 studies highlighting combinations that include a foundation of ABRAXANE® (paclitaxel protein-bound particles for injectable suspension)(albumin-bound) and gemcitabine are being presented during the 2016 ASCO Gastrointestinal Cancers Symposium (ASCO GI), establishing the therapy as the foundation for …
Share

21 April
Going Against the Grain

Walk the aisles of nearly any major grocery store and sooner or later you’ll cross paths with a “gluten-free” section. Some nutrition experts now suggest that gluten is not only harmful to those with celiac disease, but could also cause trouble for people fighting hepatitis C. Gluten is a protein …
Share